MGI(SH:688114) Hua Xia Shi Bao·2025-10-24 03:57Core Viewpoint - Recent rumors suggested that BGI Genomics is venturing into car manufacturing, which the company clarified is not the case. Instead, it focuses on using vehicles as mobile platforms for various healthcare and scientific applications [2]. Group 1: Company Clarification - BGI Genomics emphasized that it is not "manufacturing cars" but rather utilizing vehicles for mobile platforms, including automated ultrasound vehicles and mobile testing units [2]. - The company has made significant contributions in areas such as public health and medical resource distribution through its mobile platforms [2]. - BGI Genomics maintains a clear focus on its core business, prioritizing the development and manufacturing of life science tools while adhering to principles of technological synergy and scenario extension for new business ventures [2]. Group 2: Business Overview - Established in 2016, BGI Genomics is dedicated to advancing research and clinical applications through core technologies in gene sequencing and multi-omics [3]. - The company has a global presence, with operations in over 110 countries and regions, nine R&D centers, seven production bases, and 13 customer experience centers as of June 30, 2025 [2]. - BGI Genomics serves over 3,560 users worldwide, highlighting its extensive reach and impact in the life sciences sector [2].